InvestorsHub Logo
Followers 45
Posts 3487
Boards Moderated 0
Alias Born 05/26/2011

Re: OTCShotCaller post# 111527

Sunday, 08/07/2022 9:04:24 PM

Sunday, August 07, 2022 9:04:24 PM

Post# of 118379
rgbp... OTC, there is a good probability that Lilly will hold off buying anything for a while after that debacle? Heads may be rolling and new conditions set into place? If that failure is due to intrinsic difficulties in the mRNA method, then they might not trust that method any more?

Also, remember that the mRNA vaccine for Covid has been problematic as time went on, so there might be general distrust of the method? At least this time, the mRNA cancer vaccine trial that we are conducting is going to get a thorough going over before it is granted a success! Of course, there are differences in the usage of mRNA, with RGBP's method seems not to be as GENE INVASIVE as the Covid vaccine, so that just might put us in a good position? Of course that is my layman opinion!! GLTA...